Standout Papers

PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression 2017 2026 2020 2023 745
  1. PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression (2017)
    Shiping Jiao, Weiya Xia et al. Clinical Cancer Research

Immediate Impact

2 from Science/Nature 57 standout
Sub-graph 1 of 21

Citing Papers

An Antioxidative and Active Shrinkage Hydrogel Integratedly Promotes Re‐Epithelization and Skin Constriction for Enhancing Wound Closure
2024 Standout
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
2024 Standout
1 intermediate paper

Works of Mei‐Kuang Chen being referenced

EGFR and c-MET Cooperate to Enhance Resistance to PARP Inhibitors in Hepatocellular Carcinoma
2018
PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
2017 Standout

Author Peers

Author Last Decade Papers Cites
Mei‐Kuang Chen 882 516 184 337 24 1.2k
Alexandra S. Zimmer 786 350 325 179 24 1.1k
Denarda Dangaj Laniti 671 356 74 527 29 1.1k
Anita K. Mehta 437 425 111 332 20 928
Kaiming Sun 657 435 101 261 19 1.0k
Nicole Houston 627 369 122 214 40 950
Yang Peng 771 880 138 278 25 1.3k
Eileen E. Parkes 522 425 151 414 33 968
Mayu Isono 574 513 282 240 16 1.0k
Yoshihiko Hagiwara 626 732 200 277 15 1.2k
Lizhou Jia 424 455 114 223 44 937

All Works

Loading papers...

Rankless by CCL
2026